U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT06938451) titled 'Relationship Between FGF19 Overexpression and Disease Prognosis' on March 27.
Brief Summary: A real-world study of FGF19 overexpression status and treatment outcome and prognosis in advanced hepatocellular carcinoma
Study Start Date: May 01
Study Type: OBSERVATIONAL
Condition:
Hepatocellular Carcinoma (HCC)
Intervention:
OTHER:
This is an observational study and does not involve an intervention
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Beijing Tsinghua Chang Gung Hospital
Information provided by (Responsible Party): ZHAO YING, Beijing Tsinghua Chang Gung Hospital
Published by HT Digital Content Services with permis...